Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does lurbinectedin's side effect profile compare to other ovarian cancer treatments?Nextstellis cost without insurance?Scopolamine generic and brand name?Clobetasol propionate ointment 0.05?Cost of cabozantinib?
See the DrugPatentWatch profile for hyqvia
Yes. HYQVIA is a brand of subcutaneous immune globulin (human) that is marketed as the product of Halozyme Therapeutics, using its subcutaneous administration technology approach that is tied to the company’s broader development and manufacturing interests.
HYQVIA is associated with Halozyme as the company behind the product’s commercial presence in the market and its development history. Halozyme is commonly linked to HYQVIA through the company’s immune therapy platform and subcutaneous delivery approach.
For the most direct, up-to-date confirmation of who makes HYQVIA (and related IP status), DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Other Questions About Hyqvia :